Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Ichirou provides digital senior care support services that connect elderly people with caretakers.
Braizon Therapeutics is a bio-venture firm originating from the University of Tokyo and Tokyo Medical and Dental University.
RIN Institute is a bio-venture firm dedicated to the research and development of antibody-based medicines and external diagnostic drugs.
Modalis is a biotech company that develops therapeutics using CRISPR based technology.
LUCA Science develops innovative treatments intended for mitochondrial and related diseases.
Global Vascular designs and develops a drug-eluting stent delivery system using nanotechnology for lower limb artery disease.
Yukasikado is developing a business on the axis of nutrition that supports the health of the body.
Varinos is a biotechnology company that offers new genomic testing and contract analysis services.
NovAccel operates as a deep tech company.
Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.
Sonia Therapeutics is a medical equipment manufacturing company that develops a device for ultrasound treatment system.
AIRNA develops RNA editing technologies to create medicines for various diseases.
A10 Lab offers customized habit-forming solutions for businesses and organizations.
Alivexis is a biotechnology company that engages in the research and development of custom medicine for the pharmaceutical industry.
Quali develops products and solutions for microsurgery to address medical challenges and improve quality of life.
Cell fiber technology was developed as a basic technology for handling cells in the engineering field.
Mediphone is a technology-driven company that provides health management SaaS, translation, and medical interpretation services.
Shinobi Therapeutics is a biotech company that develops immune-evasive iPS cell therapies for cancer treatment.
Mentalhealth Technologies is a health care company.
ReasonWhy is a Healthcare×IT company based in Tokyo.
CYTLIMIC is a biotechnology company that develops immunotherapy products for the treatment of cancer, including a cancer peptide vaccine.
Purec is a biotech company developing culture technology for ultra-pure stem cells to enhance medical treatment efficacy.
Fast Track Initiative has invested in 37 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Fast Track Initiative's top investment sectors include Health Care, Biotechnology, Medical, Pharmaceutical, Medical Device. The firm invests across 33 different industry categories.
Among tracked funding rounds, AIRNA received $155.0M in a Series B round. Fast Track Initiative's total known invested capital is $768.6M.
Fast Track Initiative's average investment size is $20.2M across its portfolio of 37 companies.
Recent Fast Track Initiative portfolio additions include Ichirou, Braizon Therapeutics, RIN Institute, Modalis Therapeutics, LUCA Science. These companies were founded in 2020 or later.